Strategic partnership Splash Clinical recently integrated with C2N Diagnostics to offer a combined clinical trial recruitment program leveraging proprietary recruitment infrastructure and PrecivityAD2 blood tests for Alzheimer's trials. This indicates potential for co-marketing opportunities with diagnostic and biomarker partners in neurodegenerative spaces.

Specialized niche Focused on patient enrollment and patient-centered trial processes, Splash Clinical positions itself as a partner for sponsors seeking streamlined enrollment and scalable, customized solutions. This presents opportunities to upsell end-to-end recruitment services and technology-enabled workflow optimization.

Tech-forward With a tech stack including iCIMS, AWS, OneTrust, Osano, and Piwik PRO Core, Splash Clinical emphasizes data-driven recruitment, compliance, and communications. Sales opportunities exist in offering integrated or enhanced data security, consent management, and analytics enhancements to improve trial efficiency.

Growth signals Revenue range of 25 to 50 million and a growing newsletter initiative signal ongoing expansion and active thought leadership in clinical research. This creates avenues for enterprise collaborations, larger program engagements, and joint marketing or case-study opportunities.

Market alignment Recent leadership in modernizing patient enrollment aligns with sponsors seeking faster recruitment timelines and patient-centric experiences. Target parallel opportunities with sponsors exploring digital enrollment tools, patient outreach programs, and scalable recruitment infrastructure across diverse therapeutic areas.